TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SER

Serina Therapeutics Inc

Healthcare · Biotechnology

2.10$ -2.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement SER
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -15.7% -0.6% +23.8% -96.9% +6,316.2% -85.6% +530.6% -98.2% +132.1%
– -24.8% +22.8% +18.7% +28.3% +196.5% -96.2% -37.9% +115.6% -56.2%
– -4.8% -22.8% +31.4% -268.2% – – +512.6% -104.5% –
– -33.1% +1.6% -0.1% -33.0% +6.0% -58.6% +51.8% +213.2% +75.9%
– – – – – – -0.7% +202.1% +147.1% +14.3%
– -32.3% +20.4% +20.8% -30.9% -85.9% +113.5% +123.5% +173.1% +42.1%
– – – – – – – – – –
– -52.0% – – – -99.2% +413.2% +3,414.3% -5.7% -59.5%
– – – – – – – – -312.7% –
– – – – +214.9% -99.3% -8,181.4% – – –
– – – – – – – – -311.4% –
– – – – – – – – -277.2% –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?